Your browser doesn't support javascript.
loading
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.
Porter, Caroline E; Rosewell Shaw, Amanda; Jung, Youngrock; Yip, Tiffany; Castro, Patricia D; Sandulache, Vlad C; Sikora, Andrew; Gottschalk, Stephen; Ittman, Michael M; Brenner, Malcolm K; Suzuki, Masataka.
Afiliación
  • Porter CE; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA.
  • Rosewell Shaw A; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA.
  • Jung Y; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA.
  • Yip T; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA.
  • Castro PD; Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
  • Sandulache VC; Department of Otolaryngology, Baylor College of Medicine, Houston, TX, USA.
  • Sikora A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA; Department of Otolaryngology, Baylor College of Medicine, Houston, TX, USA.
  • Gottschalk S; Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Ittman MM; Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
  • Brenner MK; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Suzuki M; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX, USA. Electronic address: suzuki@bcm.edu.
Mol Ther ; 28(5): 1251-1262, 2020 05 06.
Article en En | MEDLINE | ID: mdl-32145203
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenoviridae / Inmunoterapia Adoptiva / Anticuerpos Biespecíficos / Interleucina-12 / Virus Oncolíticos / Viroterapia Oncolítica / Receptores Quiméricos de Antígenos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenoviridae / Inmunoterapia Adoptiva / Anticuerpos Biespecíficos / Interleucina-12 / Virus Oncolíticos / Viroterapia Oncolítica / Receptores Quiméricos de Antígenos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article